Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

598

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

March 31, 2022

Study Completion Date

April 4, 2023

Conditions
Alzheimer Disease
Interventions
DRUG

TRx0237 16 mg/day

Oral TRx0237 4-mg tablets administered twice daily

DRUG

Control

Oral placebo tablets (some of which contain a urinary discolorant) administered twice daily

DRUG

TRx0237 8 mg/day

Oral TRx0237 4-mg tablet administered twice daily

Trial Locations (103)

1200

Cliniques Universitaires Saint-Luc, Brussels

10312

Richmond Behavioral Associates, Staten Island

12208

Albany Medical College, Albany

13385

Timone Adults Hospital, Marseille

14203

UBMD Neurology, Buffalo

20900

Azienda Ospedaliera San Gerardo - Clinica Neurologica, Monza

22031

Re:Cognition Health, Fairfax

25125

IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia

27100

Istituto Neurologico Casimiro Mondino, IRCCS, Pavia

28015

Hospitales de Madrid, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28223

Hospital Universitario QuironSalud Madrid, Madrid

28270

Alzheimer's Memory Center, Charlotte

29414

CBRI - Roper Hospital, Charleston

29935

Coastal Neurology, Port Royal

30024

Georgia Neurology and Sleep Medicine Associates, Suwanee

30033

NeuroStudies.net, LLC, Decatur

31059

CRC Gerontopole Cite de la Sante, Hôpital La Grave, Toulouse

32127

Progressive Medical Research, Port Orange

32504

Emerald Coast Center for Neurological Disorders, Pensacola

32806

Bioclinica Research, Orlando

32952

Merrit Island Medical Research, Merritt Island

33009

MD Clinical, Hallandale

33012

Indago Research & Health Center, Inc., Hialeah

33015

Health Care Family Rehab and Research, Miami

33076

CHU Bordeaux - Pellegrin, Bordeaux

33100

Clinica Neurologica Santa Maria della Misericordia, Udine

33125

Optimus Clinical Research, Miami

33126

Biomed Research Institute, Inc, Miami

Finlay Medical Research, Miami

33133

CCM Clinical Research Group, Miami

33135

Advance Medical Research Center, Miami

Vitae Research Center, LLC, Miami

33144

L&C Professional Medical Research Institute, Miami

33155

Allied Biomedical Research Institute, Miami

33157

IMIC Inc, Palmetto Bay

33165

Future Care Solution, LLC, Miami

33173

Florida International Research Center, Miami

33176

Miami Dade Medical Research Institute, LLC, Miami

Visionary Investigators Network, Miami

33180

Visionary Investigators Network, Aventura

33414

Alzheimer's Research and Treatment Center, Wellington

33467

Finlay Medical Research, Greenacres City

33613

Stedman Clinical Trials, Tampa

34243

The Roskamp Institute, Inc., Sarasota

34295

Guidechauliac Hospital, Montpellier

34761

Sensible Healthcare, Ocoee

35009

CHU de Rennes, Rennes

37005

Centro de salud de San Juan, Unidad de Investigación Neurociencias, Salamanca

41009

Hospital Virgen de la Macarena, Seville

44093

Hôpital Laënnec - CHU de Nantes, Nantes

44321

Neuro-Behavioral Clinical Research, Inc., North Canton

44718

Neuroscience Research Center, LLC, Canton

45219

The Lindner Research Center, Cincinnati

45459

Valley Medical Research, Centerville

Neurology Diagnostics Inc., Dayton

46017

Hospital Universitario Doctor Peset, Valencia

46256

Josephson Wallack Munshower Neurology P.C., Indianapolis

69100

Hopital des Charpennes, Villeurbanne

69677

Hôpital Neurologique Pierre Wertheimer, Bron

72209

Atria Clinical Research, Little Rock

73106

IPS Research Company, Oklahoma City

74136

Tulsa Clinical Research LLC, Tulsa

85004

Xenoscience, Phoenix

85053

Arizona Research Center, Phoenix

85258

Imaging Endpoints Research, Scottsdale

87042

CHU de Limoges, Limoges

90015

Foundation Institute G.Giglio, Cefalù

91403

California Neuroscience Medical Group, Sherman Oaks

92056

Excell Research, Inc., Oceanside

92123

Sharp Mesa Vista Hospital, San Diego

92626

ATP Clinical Research, Inc., Costa Mesa

92653

Senior Clinical Trials, Inc., Laguna Hills

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

92705

Syrentis Clinical Research, Santa Ana

92708

HB Clinical Trials Inc., Fountain Valley

92835

Fullerton Neurology and Headache Center, Fullerton

97225

Neural Net Research, Portland

98405

Universal Research Group, LLC, Tacoma

99202

Kingfisher Cooperative, LLC, Spokane

08755

Advanced Memory Research of NJ PC, Toms River

V1Y 1Z9

Okanagan Clinical Trials, Ltd., Kelowna

K1Z 1G3

Memory Clinic (Ottawa), Ottawa

J8T 8J1

Clinique Mémoire de l'Outaouais, Gatineau

G3K 2P8

Alpha Recherche Clinique, Québec

06156

University of Perugia, Ospedale S.M. della Misericordia, Perugia

00186

Ospedale San Giovanni Calibita Fatebenefratelli, Roma

00189

Azienda Ospedaliera Sant'Andrea, Roma

00179

IRCCS Fondazione Santa Lucia, Rome

15-756

Podlaskie Centrum Psychogeriatrii, Bialystok

85-163

Centrum Medyczne NEUROMED, Bydgoszcz

40-123

NZOZ Wielospecjalistyczna Poradnia Lekarska Synapsis, Katowice

20-582

Indywidualna Praktyka Lekarska, Lublin

61-853

NZOZ Neuro-Kard, Poznan

70-111

Euromedis Sp. z o.o., Szczecin

01-684

Centrum Medyczne NeuroProtect, Warsaw

08195

Hospital General de Catalunya, Barcelona

08222

Hospital Universitario Mutua Terrassa, Terrassa

B16 8LT

Re:Cognition Health, Birmingham

G20 0XA

Glasgow Memory Clinic Ltd, Glasgow

GU2 7YD

Re:Cognition Health, Guildford

W1G 9JF

Re:Cognition Health - Central London, London

PL6 8BT

Re:Cognition Health, Plymouth

All Listed Sponsors
lead

TauRx Therapeutics Ltd

INDUSTRY

NCT03446001 - Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment | Biotech Hunter | Biotech Hunter